Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the rat (Q73202464)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

title

Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Linton SM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

Williams AS

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

Dodd I

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

Smith R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

Williams BD

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

Morgan BP

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

2590-2597

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083285 AND SRC:MED&resulttype=core&format=json

Physiology and pathophysiology of complement: progress and trends.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Native type II collagen--induced arthritis in the rat: the effect of complement depletion by cobra venom factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Overexpression in Escherichia coli, folding, purification, and characterization of the first three short consensus repeat modules of human complement receptor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

The Complement System in Rheumatoid Synovitis. II. Intracytoplasmic Inclusions of Immunoglobulins and Complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Complement components C1q, C1r/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Extrahepatic complement biosynthesis: where, when and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Expression of decay-accelerating factor is reduced on hyperplastic synovial lining cells in rheumatoid synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

The effects of functional suppression of a membrane-bound complement regulatory protein, CD59, in the synovial tissue in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

The immunohistology of synovial lining cells in normal and inflamed synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

CR1, CD35 in synovial fluid from patients with inflammatory joint diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Rodent models of arthritis: relevance for human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R

21 January 2018

Identifiers

DOI

0 references

1 reference